Viewing StudyNCT06078696



Ignite Creation Date: 2024-05-06 @ 7:36 PM
Last Modification Date: 2024-10-26 @ 3:10 PM
Study NCT ID: NCT06078696
Status: RECRUITING
Last Update Posted: 2023-10-12
First Post: 2023-08-30

Brief Title: Siplizumab for Sickle Cell Disease Transplant
Sponsor: Markus Mapara
Organization: Columbia University

Conditions & Keywords Data

Conditions:
Name
Anemia Sickle Cell
Keywords:
Name View
Advanced SCD View
hemoglobin S HbS Disease View
Hemoglobin S Disease View
Sickle Cell Disease View
Sickle Cell Disorders View
Sickling Disorder Due to Hemoglobin S View
Advanced Sickle Cell Disease View
Sβ0 thalassemia View